Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer

Abstract excerpt

Targeting the activation function-1 (AF-1) domain located in the N-terminus of the androgen receptor (AR) is an attractive therapeutic alternative to the current approaches to inhibit AR action in prostate cancer (PCa). Here we show that the AR AF-1 is bound by the cochaperone Bag-1L. Mutations in the AR interaction domain or loss of Bag-1L abrogate AR signaling and reduce PCa growth. Clinically, Bag-1L protein...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hormonal and reproductive studies
• Share to Mass Spectrometry Techniques and Applications
• Share to Prostate Cancer Treatment and Research